English  |  正體中文  |  简体中文  |  Total items :2826576  
Visitors :  32007220    Online Users :  1053
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"pei jer chen"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 646-670 of 883  (36 Page(s) Totally)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:33:28Z Gender difference in the association between metabolic factors and hepatocellular carcinoma Chen C.-L.; Kuo M.-J.; Ming-Fang Yen A.; Yang W.-S.; Kao J.-H.; PEI-JER CHEN; Chen H.-H.
臺大學術典藏 2021-07-03T03:33:28Z Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis Su T.-H.; Peng C.-Y.; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:28Z A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice Zhang T.-Y.; Guo X.-R.; Wu Y.-T.; Kang X.-Z.; Zheng Q.-B.; Qi R.-Y.; Chen B.-B.; Lan Y.; Wei M.; Wang S.-J.; Xiong H.-L.; Cao J.-L.; Zhang B.-H.; Qiao X.-Y.; Huang X.-F.; Wang Y.-B.; Fang M.-J.; Zhang Y.-L.; Cheng T.; Chen Y.-X.; Zhao Q.-J.; Li S.-W.; Ge S.-X.; PEI-JER CHEN; Zhang J.; Yuan Q.; Xia N.-S.
臺大學術典藏 2021-07-03T03:33:28Z Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus Sung C.-C.; Horng J.-H.; Siao S.-H.; Chyuan I.-T.; Tsai H.-F.; PEI-JER CHEN; Hsu P.-N.
臺大學術典藏 2021-07-03T03:33:27Z Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver Ho T.-C.; Wang E.-Y.; Yeh K.-H.; Jeng Y.-M.; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; Hsu C.-L.; PEI-JER CHEN; Yeh S.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:27Z Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy Tseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:27Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan Liu C.-H.; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:26Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:26Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:26Z HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice Horng J.-H.; Lin W.-H.; Wu C.-R.; Lin Y.-Y.; Wu L.-L.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:26Z Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals Liu C.-H.; Lee M.-H.; Lin J.-W.; Liu C.-J.; Su T.-H.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:25Z Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) Chang F.-Y.; Chen H.-C.; PEI-JER CHEN; Ho M.-S.; Hsieh S.-L.; Lin J.-C.; Liu F.-T.; Sytwu H.-K.
臺大學術典藏 2021-07-03T03:33:25Z Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection Cheng X.; Uchida T.; Xia Y.; Umarova R.; Liu C.-J.; PEI-JER CHEN; Gaggar A.; Suri V.; M?cke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J.
臺大學術典藏 2021-07-03T03:33:25Z 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.
臺大學術典藏 2021-07-03T03:33:24Z Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan Lin G.-Y.; Wu Y.-L.; Wang C.-S.; Ko C.-Y.; Chen C.-H.; PEI-JER CHEN; Peng P.-H.; Hsu C.-W.
臺大學術典藏 2021-07-03T03:33:24Z The origin and underlying driving forces of the SARS-CoV-2 outbreak Chaw S.-M.; Tai J.-H.; Chen S.-L.; Hsieh C.-H.; Chang S.-Y.; Yeh S.-H.; Yang W.-S.; PEI-JER CHEN; Wang H.-Y.
臺大學術典藏 2021-07-03T03:33:24Z Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing Yang Y.-C.; Chen Y.-H.; Kao J.-H.; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Yang H.-C.
臺大學術典藏 2021-07-03T03:33:23Z Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-07-03T03:33:23Z 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.
臺大學術典藏 2021-07-03T03:33:23Z The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient Wang J.-T.; Lin Y.-Y.; Chang S.-Y.; Yeh S.-H.; Hu B.-H.; PEI-JER CHEN; Chang S.-C.
臺大學術典藏 2021-07-03T03:33:23Z Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:22Z Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials Asahina Y.; Liu C.-J.; Gane E.; Itoh Y.; Kawada N.; Ueno Y.; Youn J.; Wang C.-Y.; Llewellyn J.; Matsuda T.; Gaggar A.; Mo H.; Dvory-Sobol H.; Crans G.; Chuang W.-L.; PEI-JER CHEN; Enomoto N.
臺大學術典藏 2021-07-03T03:33:22Z Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan Su H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; Su T.-H.; PEI-JER CHEN; Liu C.-J.
臺大學術典藏 2021-07-03T03:33:22Z Disease burden from foodborne illnesses in Taiwan, 2012–2015 Lai Y.-H.; Chung Y.-A.; Wu Y.-C.; Fang C.-T.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:33:22Z Elimination of hepatitis B in highly endemic settings: Lessons learned in Taiwan and challenges ahead Liu C.-J.; PEI-JER CHEN

Showing items 646-670 of 883  (36 Page(s) Totally)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
View [10|25|50] records per page